Global Transthyretin Amyloidosis Treatment Market–Analysis and Demand with Forecast Overview to 2029 - by PMI
January 25, 2021 11:05 ET
|
PMI
Covina CA, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Robust pipeline of transthyretin amyloidosis treatment drugs is one of the major factors that is expected to propel growth of the market over the...
STOCK ALERT: Rosen Law Firm Reminds Valeant Pharmaceuticals International, Inc. Investors of Important December 21, 2015 Deadline in Class Action Filed by the Firm - VRX
December 10, 2015 17:50 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 10, 2015 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) securities from February...
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Valeant Pharmaceuticals International, Inc. - VRX
November 20, 2015 17:43 ET
|
The Rosen Law Firm PA
NEW YORK, Nov. 20, 2015 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Valeant Pharmaceuticals...